More than 1.2 million cholera rapid diagnostic tests (RDTs) are set to be dispatched to 14 countries in a stride towards combating the global surge in cholera cases.
The inaugural shipment, landing today in Malawi, marks the initiation of this deployment under the auspices of Gavi, the Vaccine Alliance.
The primary objective of this initiative is to enhance the prompt detection and monitoring of cholera outbreaks, thereby fortifying the efficacy of vaccination campaigns amidst ongoing crises and facilitating the targeted distribution of preventive vaccination endeavours.
This global procurement program for cholera rapid diagnostic tests is the result of collaborative efforts between Gavi, the World Health Organization (WHO), UNICEF, the Foundation for Innovative New Diagnostics (FIND), and various other partners.
Under the aegis of Gavi, the Vaccine Alliance, and with procurement and delivery spearheaded by UNICEF, this global cholera diagnostics program is poised to significantly enhance disease surveillance and outbreak response mechanisms.
Leveraging insights gleaned from pilot studies conducted across regions such as the Democratic Republic of the Congo, Niger, and Nepal, the program has been meticulously crafted to optimise its efficacy at scale.
Cholera, an acute intestinal infection transmitted through contaminated food and water, has witnessed a global resurgence since 2021, underscored by alarmingly high case fatality rates.
The 14 countries receiving 1.2 million cholera diagnostic tests in the largest global deployment include: